本页面由Tiger Trade Technology Pte. Ltd.提供服务

Avricore Health Inc.

0.0606
0.0000
成交量:- -
成交额:- -
市值:613.31万
市盈率:-4.15
高:0.0606
开:0.0606
低:0.0606
收:0.0606
52周最高:0.0787
52周最低:0.0166
股本:1.01亿
流通股本:9,257.44万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.0146
每股收益(LYR):-0.0062
净资产收益率:-86.10%
总资产收益率:-23.12%
市净率:6.52
市盈率(LYR):-9.80

数据加载中...

2025/06/16

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/06/12

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/06/16

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/12/20

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/12/08

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/06/17

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2018/06/19

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2018/05/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2017/05/25

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2016/04/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2015/11/13

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2015/03/02

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2015/02/23

SEC问询函

CORRESP [Cover] - Correspondence
2014/11/20

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2014/02/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]